COVID-19 in Northeast Brazil: preliminary characteristics of deaths

Authors

DOI:

https://doi.org/10.33448/rsd-v9i11.10166

Keywords:

Coronavirus; Coronavirus infections; Brazil; Epidemiology descriptive; Health services research.

Abstract

Objective: to describe the characteristics of deaths in the Northeast region of Brazil. Methods: a descriptive study based on epidemiological bulletins released by the health departments of each state in the Northeast on the cases of COVID-19, until July 20, 2020, the mortality rate was calculated, a set of deaths aged over 60 years , sex and presence or not of comorbidity, in addition to an individual analysis by state of the most common associated diseases. Results: Ceará was the state with the most cases and deaths, and Piauí the least number of cases and deaths, the region's mortality rate is 3.6%. Most deaths in the region were composed of men with more 60 years old, with some associated comorbidity, mainly cardiovascular diseases, followed by diabetes mellitus. Conclusion: the features show similarities in comparison with the seen preliminary results in other locations around the world.

References

Allam, M., Cai, S., Ganesh, S., Venkatesan, M., Doodhwala, S., Song, Z., et al. COVID-19 Diagnostics, Tools, and Prevention. Diagnostics (Basel). 10 (6): 409. doi: 10.3390/diagnostics10060409

Ayalon, L., Chasteen, A., Diehl, M., Levy, B., Neupert, S. D., Rothermund, K., et al. Aging in times of the COVID-19 pandemic: Avoiding ageism and fostering intergenerational solidarity. J Gerontol B Psychol Sci Soc Sci. 2020 Apr; gbaa051. doi: 10.1093/geronb/gbaa051

Barros, G. M., Mazullo Filho, J. B. R., Mendes Júnior, A. C. Considerações sobre a relação entre a hipertensão e o prognóstico da COVID-19. J. Health Biol. Sci. 2020; 8(1), 1-3. .doi: 10.12662/2317-3076jhbs.v8i1.3250.p1-3.2020

Brasil. Ministério da Saúde. Painel Coronavírus. [Internet]. 2020. Secretaria de Vigilância em Saúde (SVS): Guia de Epidemiológica. Secretarias Estaduais e Municipais de Saúde. 2020 https://covid.saude.gov.br/

Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. Vigitel Brasil 2014 : vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. – Brasília: Ministério da Saúde, 2015. http://bvsms.saude.gov.br/bvs/publicacoes/vigitel_brasil_2014.pdf

Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 may; 97 (5): 829-838. doi: 10.1016/j.kint.2020.03.005

Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020 May; 75 (18): 2352-2371. doi: 10.1016/j.jacc.2020.03.031

Emami, A., Javanmardi, F., Pirbonyeh, N., Akbari, A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020; 8 (1) e35. doi: 10.22037/aaem.v8i1.600

Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Nicklin, S. A. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020 Aug; 116 (10): 1666-1687. doi: 10.1093/cvr/cvaa106

Heo, J. Y., Song, J. Y., Noh, J. Y., Choi, M. J., Yoon, J. G., Lee, S. N., et al. Effects of influenza immunization on pneumonia in the elderly. Hum Vaccin Immunother. (3): 744-749. doi: 10.1080/21645515.2017.1405200

Iba, T., Levy, J. H., Levi, M., Thachil, J. Coagulopathy in COVID-19. J Thromb Haemost. 2020 Jun. doi: 10.1111/jth.14975.

Ji, D., et al. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL Score. Clin Infect Dis. 2020 Apr. doi: 10.1093/cid/ciaa414

Jordan, R. E., Adab, P., Cheng, K. K. Covid-19: risk factors for severe disease and death. BMJ. 368:m1198. doi: 10.1136/bmj.m1198.

Liu, K., Chen, Y., Lin, R., Han, K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 80 (6): e14–e18. doi: 10.1016/j.jinf.2020.03.005

Niu, S., et al. Clinical characteristics of older patients infected with COVID-19: A descriptive study. Arch Gerontol Geriatr. 2020 jul-aug; 89: 104058. doi: 10.1016 / j.archger.2020.104058

Odegaard, J. I., Chawla, A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med. 2 (3): a007724. doi: 10.1101/cshperspect.a007724

Parohan, M., et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 1-9. doi: 10.1080/13685538.2020.1774748

Pinky, L., Dobrovolny, H. M. SARS‐CoV‐2 coinfections: Could influenza and the common cold be beneficial? J Med Virol. 2020 May. doi: 10.1002/jmv.26098

Qin, C., et al.. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 71 (15): 762-768. doi: 10.1093/cid/ciaa248.

Rubino, S., Kelvin, N., Bermejo-Martin, J. F., Kelvin, D. As COVID-19 cases, deaths and fatality rates surge in Italy, underlying causes require investigation. J Infect, 14 (3): 265-267. doi: 10.3855/jidc.12734

Sattar, N., McInnes, I. B., McMurray, J. J. Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020 jul; 142 (1): 4-6. doi: 10.1161/CIRCULATIONAHA.120.047659.

Who, World Health Organization. Timeline of WHO’s response to COVID-19. 2020. https://www.who.int/news-room/detail/29-06-2020-covidtimeline

Wilson, N., Kvalsvig, A., Barnard, L. T., Baker, M. G. Case-fatality risk estimates for COVID-19 calculated by using a lag time for fatality. Emerg Infect Dis. 26 (6): 1339–1441. doi: 10.3201/eid2606.200320

Wu, J. Tackle the free radicals damage in COVID-19. Nitric Oxide. 2020 Sep; 102:39-41. doi: 10.1016/j.niox.2020.06.002

Wu, Z, McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020 feb; 323 (13): 1239-1242. doi: 10.1001 / jama.2020.2648

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Zhou, Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 94, 91-95. doi: 10.1016/j.ijid.2020.03.017

Ying, J. C., Seng, K. T., Ester, Y. Dissecting the Interaction Between Coronavirus Disease 2019 and Diabetes Mellitus. J Diabetes Investig. doi: 10.1111/jdi.13326

Yu, W. L., Toh, H. S., Liao, C. T., Chang, W. T. A Double-Edged Sword—Cardiovascular Concerns of Potential Anti-COVID-19 Drugs. Cardiovasc Drugs Ther. 1–10. doi: 10.1007/s10557-020-07024-7

Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 81 (2): e16–e25. doi: 10.1016/j.jinf.2020.04.021

Published

06/12/2020

How to Cite

BARROS, G. M. de; BARROS, G. M. de . COVID-19 in Northeast Brazil: preliminary characteristics of deaths. Research, Society and Development, [S. l.], v. 9, n. 11, p. e89291110166, 2020. DOI: 10.33448/rsd-v9i11.10166. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/10166. Acesso em: 8 oct. 2024.

Issue

Section

Health Sciences